Mirae Asset Global Investments Co. Ltd. Buys 3,738 Shares of Azenta, Inc. (NASDAQ:AZTA)

Mirae Asset Global Investments Co. Ltd. raised its position in shares of Azenta, Inc. (NASDAQ:AZTA) by 7.7% during the 4th quarter, HoldingsChannel.com reports. The fund owned 52,231 shares of the company’s stock after acquiring an additional 3,738 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Azenta were worth $3,402,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Allworth Financial LP grew its stake in Azenta by 273.1% in the fourth quarter. Allworth Financial LP now owns 1,634 shares of the company’s stock worth $106,000 after purchasing an additional 1,196 shares during the period. Pacer Advisors Inc. grew its position in shares of Azenta by 28.7% in the 4th quarter. Pacer Advisors Inc. now owns 9,042 shares of the company’s stock worth $589,000 after buying an additional 2,018 shares during the period. Raymond James & Associates increased its stake in shares of Azenta by 0.3% in the 4th quarter. Raymond James & Associates now owns 96,126 shares of the company’s stock worth $6,262,000 after acquiring an additional 285 shares in the last quarter. Handelsinvest Investeringsforvaltning purchased a new position in Azenta during the 4th quarter valued at about $298,000. Finally, Exchange Traded Concepts LLC boosted its stake in Azenta by 2.7% during the fourth quarter. Exchange Traded Concepts LLC now owns 467,003 shares of the company’s stock worth $30,421,000 after acquiring an additional 12,371 shares in the last quarter. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on AZTA. Stephens reaffirmed an “equal weight” rating and set a $70.00 target price on shares of Azenta in a research note on Thursday, February 8th. B. Riley raised their price objective on Azenta from $61.00 to $79.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Needham & Company LLC reissued a “buy” rating and issued a $75.00 target price on shares of Azenta in a report on Monday, April 8th. Jefferies Financial Group started coverage on Azenta in a report on Thursday, April 4th. They set a “hold” rating and a $64.00 price target for the company. Finally, Evercore ISI lowered their price target on Azenta from $64.00 to $60.00 and set an “in-line” rating for the company in a research report on Thursday, April 4th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $69.60.

Azenta Trading Down 1.9 %

Shares of AZTA opened at $51.17 on Thursday. The company has a market cap of $2.85 billion, a price-to-earnings ratio of -165.06 and a beta of 1.53. The business’s fifty day simple moving average is $61.24 and its two-hundred day simple moving average is $58.97. Azenta, Inc. has a 12 month low of $36.01 and a 12 month high of $69.16.

Azenta (NASDAQ:AZTA) last released its quarterly earnings data on Wednesday, February 7th. The company reported $0.02 EPS for the quarter. Azenta had a positive return on equity of 0.49% and a negative net margin of 2.92%. The company had revenue of $154.32 million for the quarter, compared to analysts’ expectations of $151.86 million. As a group, research analysts forecast that Azenta, Inc. will post 0.27 EPS for the current year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.